Lotensin HCT

Product NDC: 30698-454
Requested package NDC: 30698-454-01
11-digit product format: 306980454
Labeler code: 30698
Product ID: 30698-454_4b9222f7-7b31-4781-e063-6394a90ab188
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: benazepril hydrochloride and hydrochlorothiazide
Dosage form: TABLET
Route: ORAL
Labeler: Validus Pharmaceuticals LLC
Application: NDA020033
Marketing category: NDA
Marketing start: 1992-05-30
Substance: BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Active strength: 20; 25 mg/1; mg/1
Pharmacologic classes: Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 8 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-08-27 00:01 UTC · source 2025-08-26	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020033-001	LOTENSIN HCT	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19
N020033-002	LOTENSIN HCT	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19
N020033-003	LOTENSIN HCT	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20MG;25MG	TABLET / ORAL	AB	RLD	1992-05-19
N020033-004	LOTENSIN HCT	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N020033-002	AB
N020033-003	AB
N020033-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD	1992-05-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020033-001	LOTENSIN HCT	5MG;6.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	1992-05-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020033-002	LOTENSIN HCT	10MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020033-003	LOTENSIN HCT	20MG;25MG	TABLET / ORAL	AB	RLD, RS	1992-05-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020033-004	LOTENSIN HCT	20MG;12.5MG	TABLET / ORAL	AB	RLD	1992-05-19	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020033-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020033-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020033-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020033-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020033-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020033-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020033-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020033-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020033-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020033-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020033-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020033-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020033-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020033-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020033-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020033-004	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020033-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020033-003	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020033-004	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020033-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020033-003	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020033-004	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020033-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020033-003	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020033-004	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020033-002	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Lotensin HCT
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BENAZEPRIL HYDROCHLORIDE	20 mg/1
HYDROCHLOROTHIAZIDE	25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
N1SN99T69T	Internal UNII lookup
0J48LPH2TH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
898362	Internal RxNorm lookup
898366	Internal RxNorm lookup
898367	Internal RxNorm lookup
898371	Internal RxNorm lookup
898372	Internal RxNorm lookup
898376	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
94c4536f-e28e-48b1-8336-b3939917e99d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
a4484670-2869-6416-f6ff-03b1b3cbd1b0	Product name	2	20190415
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
b9fbc696-7d55-c52e-4f12-7e3d99cd2db4	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2025-09-30	Lotensin HCT
2025-01-30	Lotensin HCT
2023-02-17	Lotensin HCT
2023-01-30	Lotensin HCT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
30698-454-01	Lotensin HCT	100 in 1 BOTTLE	TABLET	100		15

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
30698-454-01	EA - Each	30698-454	6ec4eb6e-ede5-4df5-9873-c6076478caa9	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BENAZEPRIL HYDROCHLORIDE	ACTIVE INGREDIENT	N1SN99T69T	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
BENAZEPRILAT	ACTIVE MOIETY	JRM708L703	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
HYDROGENATED CASTOR OIL	INACTIVE INGREDIENT	ZF94AP8MEY	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
30698-454	LOTENSIN HCT (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) TABLET [VALIDUS PHARMACEUTICALS LLC]	13	Current NDC, Legacy NDC, 1 package rows	20231110_94c4536f-e28e-48b1-8336-b3939917e99d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lotensin HCT	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	Validus Pharmaceuticals LLC	94c4536f-e28e-48b1-8336-b3939917e99d	2026-02-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020033 application number: NDA020033 ndc (package): 30698-454-01 ndc (product): 30698-454 ndc11 (package): 30698045401
benazepril hydrochloride and hydrochlorothiazide	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	Advagen Pharma Ltd	3f6e6da8-6da3-47c5-a151-e6fd7206890e	2026-02-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020033 application number: NDA020033
benazepril hydrochloride and hydrochlorothiazide	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	Bryant Ranch Prepack	f4120568-dd9b-47a5-bd44-4de6ed343bbe	2024-06-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020033 application number: NDA020033
benazepril hydrochloride and hydrochlorothiazide	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	Padagis US LLC	3e2d3974-38b0-49d0-8020-f74107584724	2023-05-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020033 application number: NDA020033

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N1SN99T69T	BENAZEPRIL HYDROCHLORIDE	86541-74-4	BENAZEPRIL HYDROCHLORIDE
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
898362	benazepril HCl 10 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	94c4536f-e28e-48b1-8336-b3939917e99d	15
898367	benazepril HCl 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	94c4536f-e28e-48b1-8336-b3939917e99d	15
898372	benazepril HCl 20 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	94c4536f-e28e-48b1-8336-b3939917e99d	15
898366	Lotensin HCT 10 MG / 12.5 MG Oral Tablet	PSN	94c4536f-e28e-48b1-8336-b3939917e99d	15
898371	Lotensin HCT 20 MG / 12.5 MG Oral Tablet	PSN	94c4536f-e28e-48b1-8336-b3939917e99d	15
898376	Lotensin HCT 20 MG / 25 MG Oral Tablet	PSN	94c4536f-e28e-48b1-8336-b3939917e99d	15
898366	benazepril hydrochloride 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Lotensin HCT]	SBD	94c4536f-e28e-48b1-8336-b3939917e99d	15
898371	benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Lotensin HCT]	SBD	94c4536f-e28e-48b1-8336-b3939917e99d	15
898376	benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet [Lotensin HCT]	SBD	94c4536f-e28e-48b1-8336-b3939917e99d	15
898362	benazepril hydrochloride 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet	SCD	94c4536f-e28e-48b1-8336-b3939917e99d	15
898367	benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet	SCD	94c4536f-e28e-48b1-8336-b3939917e99d	15
898372	benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet	SCD	94c4536f-e28e-48b1-8336-b3939917e99d	15
898362	benazepril hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898367	benazepril hydrochloride 20 MG / HCTZ 12.5 MG Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898372	benazepril hydrochloride 20 MG / HCTZ 25 MG Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898362	BZP hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898366	BZP hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet [Lotensin HCT]	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898367	BZP hydrochloride 20 MG / HCTZ 12.5 MG Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898371	BZP hydrochloride 20 MG / HCTZ 12.5 MG Oral Tablet [Lotensin HCT]	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898372	BZP hydrochloride 20 MG / HCTZ 25 MG Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898376	BZP hydrochloride 20 MG / HCTZ 25 MG Oral Tablet [Lotensin HCT]	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898371	Lotensin HCT (benazepril HCl 20 MG / HCTZ 12.5 MG) Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898376	Lotensin HCT (benazepril HCl 20 MG / HCTZ 25 MG) Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898366	Lotensin HCT 10/12.5 (benazepril HCl / HCTZ) Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898366	Lotensin HCT 10/12.5 Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898371	Lotensin HCT 20/12.5 Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15
898376	Lotensin HCT 20/25 Oral Tablet	SY	94c4536f-e28e-48b1-8336-b3939917e99d	15

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
30698-454-01	30698045401	100 TABLET in 1 BOTTLE (30698-454-01)	100 tablet	1992-05-30	0000-00-00	No	No	Current